vs

Side-by-side financial comparison of electroCore, Inc. (ECOR) and Li Bang International Corp Inc. (LBGJ). Click either name above to swap in a different company.

electroCore, Inc. is the larger business by last-quarter revenue ($9.2M vs $4.7M, roughly 2.0× Li Bang International Corp Inc.). Li Bang International Corp Inc. runs the higher net margin — -23.9% vs -32.8%, a 9.0% gap on every dollar of revenue.

electroCore, Inc. is a medical technology company based in Basking Ridge, New Jersey. electroCore was co-founded in 2005 by JP Errico, Thomas J. Errico, MD, Charles Theofilos, MD, and Peter Staats, MD. The current chief executive officer is Daniel S. Goldberger. electroCore has one product called gammaCore, a non-invasive, commercially available product that uses vagus nerve stimulation.

Li & Fung Limited is a Hong Kong–based supply chain management company. Established in 1906, the company became publicly traded in 1973 and has since played a significant role in manufacturing apparel, toys, and various consumer goods for major North American and European retailers. Significant growth occurred after its public listing, reaching a peak market capitalization in 2011, but the rise of platforms like Alibaba and Amazon, which directly connect manufacturers with consumers, created ...

ECOR vs LBGJ — Head-to-Head

Bigger by revenue
ECOR
ECOR
2.0× larger
ECOR
$9.2M
$4.7M
LBGJ
Higher net margin
LBGJ
LBGJ
9.0% more per $
LBGJ
-23.9%
-32.8%
ECOR

Income Statement — Q4 FY2025 vs Q4 FY2024

Metric
ECOR
ECOR
LBGJ
LBGJ
Revenue
$9.2M
$4.7M
Net Profit
$-3.0M
$-1.1M
Gross Margin
88.4%
17.8%
Operating Margin
-31.8%
-25.1%
Net Margin
-32.8%
-23.9%
Revenue YoY
31.2%
Net Profit YoY
6.0%
EPS (diluted)
$-0.34
$-0.06

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECOR
ECOR
LBGJ
LBGJ
Q4 25
$9.2M
Q3 25
$8.7M
Q2 25
$7.4M
Q1 25
$6.7M
Q4 24
$7.0M
$4.7M
Q3 24
$6.6M
Q2 24
$6.1M
Q1 24
$5.4M
Net Profit
ECOR
ECOR
LBGJ
LBGJ
Q4 25
$-3.0M
Q3 25
$-3.4M
Q2 25
$-3.7M
Q1 25
$-3.9M
Q4 24
$-3.2M
$-1.1M
Q3 24
$-2.5M
Q2 24
$-2.7M
Q1 24
$-3.5M
Gross Margin
ECOR
ECOR
LBGJ
LBGJ
Q4 25
88.4%
Q3 25
86.0%
Q2 25
87.3%
Q1 25
84.9%
Q4 24
85.9%
17.8%
Q3 24
83.8%
Q2 24
86.3%
Q1 24
83.7%
Operating Margin
ECOR
ECOR
LBGJ
LBGJ
Q4 25
-31.8%
Q3 25
-33.2%
Q2 25
-47.5%
Q1 25
-56.9%
Q4 24
-43.6%
-25.1%
Q3 24
-40.4%
Q2 24
-42.2%
Q1 24
-70.7%
Net Margin
ECOR
ECOR
LBGJ
LBGJ
Q4 25
-32.8%
Q3 25
-39.2%
Q2 25
-49.7%
Q1 25
-57.4%
Q4 24
-45.8%
-23.9%
Q3 24
-38.1%
Q2 24
-43.2%
Q1 24
-64.4%
EPS (diluted)
ECOR
ECOR
LBGJ
LBGJ
Q4 25
$-0.34
Q3 25
$-0.40
Q2 25
$-0.44
Q1 25
$-0.47
Q4 24
$-0.37
$-0.06
Q3 24
$-0.31
Q2 24
$-0.38
Q1 24
$-0.53

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECOR
ECOR
LBGJ
LBGJ
Cash + ST InvestmentsLiquidity on hand
$11.6M
Total DebtLower is stronger
$7.8M
$10.2M
Stockholders' EquityBook value
$-1.7M
$7.8M
Total Assets
$18.7M
$28.8M
Debt / EquityLower = less leverage
1.31×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECOR
ECOR
LBGJ
LBGJ
Q4 25
$11.6M
Q3 25
$13.0M
Q2 25
$7.1M
Q1 25
$7.8M
Q4 24
$12.2M
Q3 24
$12.9M
Q2 24
$14.2M
Q1 24
$7.8M
Total Debt
ECOR
ECOR
LBGJ
LBGJ
Q4 25
$7.8M
Q3 25
$7.8M
Q2 25
Q1 25
Q4 24
$10.2M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ECOR
ECOR
LBGJ
LBGJ
Q4 25
$-1.7M
Q3 25
$-1.1M
Q2 25
$1.1M
Q1 25
$4.4M
Q4 24
$7.5M
$7.8M
Q3 24
$9.5M
Q2 24
$11.5M
Q1 24
$4.5M
Total Assets
ECOR
ECOR
LBGJ
LBGJ
Q4 25
$18.7M
Q3 25
$21.4M
Q2 25
$14.6M
Q1 25
$16.0M
Q4 24
$20.5M
$28.8M
Q3 24
$21.0M
Q2 24
$22.4M
Q1 24
$13.9M
Debt / Equity
ECOR
ECOR
LBGJ
LBGJ
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
1.31×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECOR
ECOR
LBGJ
LBGJ
Operating Cash FlowLast quarter
$-1.5M
$258.4K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECOR
ECOR
LBGJ
LBGJ
Q4 25
$-1.5M
Q3 25
$-1.7M
Q2 25
$-623.0K
Q1 25
$-4.4M
Q4 24
$-1.3M
$258.4K
Q3 24
$-1.4M
Q2 24
$-1.8M
Q1 24
$-2.6M
Free Cash Flow
ECOR
ECOR
LBGJ
LBGJ
Q4 25
Q3 25
$-1.7M
Q2 25
$-648.0K
Q1 25
$-4.4M
Q4 24
Q3 24
Q2 24
Q1 24
FCF Margin
ECOR
ECOR
LBGJ
LBGJ
Q4 25
Q3 25
-19.3%
Q2 25
-8.8%
Q1 25
-65.4%
Q4 24
Q3 24
Q2 24
Q1 24
Capex Intensity
ECOR
ECOR
LBGJ
LBGJ
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.3%
Q1 25
0.6%
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons